SeaStar Medical Holding Corporation Total Liabilities
SeaStar Medical Holding Corporation total liabilities. Based on the latest financial reports, SeaStar Medical Holding Corporation (ICU) has total liabilities worth $4.35 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SeaStar Medical Holding Corporation (ICU) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of SeaStar Medical Holding Corporation (2020–2025)
Total liabilities of SeaStar Medical Holding Corporation from 2020 to 2025. This chart illustrates how SeaStar Medical Holding Corporation's total liabilities have evolved over time, based on quarterly financial data.
SeaStar Medical Holding Corporation Competitors by Total Liabilities
The table below lists competitors of SeaStar Medical Holding Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bridgeline Digital Inc
NASDAQ:BLIN
|
USA | $6.18 Million |
|
Indonesian Tobacco Tbk PT
JK:ITIC
|
Indonesia | Rp184.04 Billion |
|
ESV Inc
KQ:223310
|
Korea | ₩44.53 Billion |
|
RE Royalties Ltd
V:RE
|
Canada | CA$45.99 Million |
|
Magna Polonia SA
WAR:06N
|
Poland | zł8.86 Million |
|
Greenvale Energy Ltd
AU:GRV
|
Australia | AU$281.21K |
|
Barfresh Food Group Inc
NASDAQ:BRFH
|
USA | $12.81 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down SeaStar Medical Holding Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see ICU total asset value.
Liquidity & Leverage Metrics
SeaStar Medical Holding Corporation Total Liabilities Ratios Explained
SeaStar Medical Holding Corporation total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SeaStar Medical Holding Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SeaStar Medical Holding Corporation (2020–2025)
The table below shows the annual total liabilities of SeaStar Medical Holding Corporation from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $3.74 Million | -45.30% |
| 2024-12-31 | $6.84 Million | -60.65% |
| 2023-12-31 | $17.38 Million | -26.96% |
| 2022-12-31 | $23.80 Million | +596.11% |
| 2021-12-31 | $3.42 Million | -95.41% |
| 2020-12-31 | $74.49 Million | -- |
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperi… Read more